DGY-06-116 blocks the activity of Src kinases, which are involved in various cellular processes such as growth, differentiation, and survival, and have been implicated in the progression of several cancers and other diseases.
Molecular Weight
597.12
Molecular Formula
C32H33ClN8O2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
DGY-06-116 targets Src, exploring therapeutic pathways in cancer driven by Src signaling.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
